Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Phenoxymethylpenicillin potassium 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Phenylephrine hydrochloride 25 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Atropine sulfate 620 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Atropine sulfate 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cyclopentolate hydrochloride 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Ecothiopate iodide 300 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride 500 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely ecothiopate iodide 600 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Ecothiopate iodide 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Glycerol 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Ecothiopate iodide 1.25 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
karboximetylcellulosanatrium 5 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Glycerol 500 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
karboximetylcellulosanatrium 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Methylcellulose 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
tropikamid 5 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
tropikamid 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Lomefloxacin 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Hypromellose 3.2 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Carbachol 15 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Guanethidine 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
apraklonidin (som apraklonidinhydroklorid) 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Levobunolol hydrochloride 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Povidone 50 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timolol (som timololmaleat) 2,5 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
timolol (som timololmaleat) 5 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Dibrompropamidine isetionate 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Metipranolol 1 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Metipranolol 3 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
Has manufactured dose form |
True |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|
Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has manufactured dose form |
False |
Conventional release eye solution (dose form) |
Inferred relationship |
Some |
|